Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Current Assets (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Current Assets for 2 consecutive years, with $4.8 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Assets changed N/A year-over-year to $4.8 million, compared with a TTM value of $4.8 million through Jun 2025, changed N/A, and an annual FY2024 reading of $4.2 million, changed N/A over the prior year.
  • Current Assets was $4.8 million for Q2 2025 at Kairos Pharma, down from $6.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $6.0 million in Q1 2025 and bottomed at $4.2 million in Q4 2024.